Urology Partners of America has officially announced its rebranding to Unio Health Partners (UHP), marking a significant evolution for the physician services platform. This strategic shift reflects UHP’s growth beyond urology, now encompassing gastroenterology and radiation oncology, and its commitment to serving independent physicians across the Western United States. Founded in 2021 with backing from Triton Pacific Capital Partners, Unio Health Partners has rapidly expanded, partnering with multiple physician practices and establishing a strong presence in the healthcare landscape.
In just its first year, Unio Health Partners has demonstrated impressive growth, collaborating with four physician practices in the San Diego and Los Angeles regions. This expansion has brought the platform to a robust network of 75 providers, including 50 physicians and 25 advanced practice providers operating across 21 locations. The rebranding to Unio Health Partners signals the company’s successful diversification into gastroenterology and radiation oncology, solidifying its position as a comprehensive multi-specialty platform dedicated to supporting independent physicians.
Marshal Salomon, Chief Executive Officer of Unio Health Partners, emphasized the strategic rationale behind the rebranding. “Urology, gastroenterology, and radiation oncology are highly complementary specialties,” Salomon stated. “UHP’s new name reflects the maturation of our organization, continued growth across all three specialties, and our core mission of supporting and enhancing independent private practice.” This statement underscores the company’s vision to create a synergistic healthcare ecosystem benefiting both physicians and patients.
Dr. Ed Cohen, President of Unio Health Partners, echoed this sentiment, highlighting the exciting prospects for further expansion. “We are excited to further expand our gastroenterology and radiation oncology divisions and to continue building a preeminent multi-specialty physician services platform in partnership with UHP,” Dr. Cohen commented. He further emphasized that “This rebranding highlights UHP’s commitment to urologists, gastroenterologists, and radiation oncologists, as well as the patients they serve,” reinforcing the patient-centric approach of Unio Health Partners.
Dr. Robert Goldklang, Division Head of Gastroenterology, further articulated the significance of the rebranding, stating, “‘UHP’ is both the culmination of our successes to date and the foundation of a transformational future.” This forward-looking perspective emphasizes that the name change is not just a reflection of past achievements but also a declaration of intent for continued innovation and growth in the healthcare sector.
About Unio Health Partners
Unio Health Partners, supported by Triton Pacific Capital Partners, is uniquely positioned as a physician services platform committed to transforming healthcare delivery in urology, gastroenterology, and radiation oncology throughout the Western United States. The platform distinguishes itself by forging partnerships with leading physician practices, fostering a unified, quality-focused clinical culture, and promoting the sharing of best practices across its network. By joining Unio Health Partners, affiliated practices gain access to an expanded suite of services, delivering substantial advantages to both healthcare providers and their patients.
Initially concentrating on the fragmented healthcare market of the Western U.S., Unio Health Partners is strategically building significant size, scale, and geographic reach. This expansion is designed to enhance the platform’s value proposition for all stakeholders, creating a robust and efficient healthcare ecosystem. Unio Health Partners was established in May 2021 with the acquisition of Genesis Healthcare Partners MSO and a partnership with Genesis Healthcare Partners physicians, demonstrating a strong foundation for growth and innovation.
UHP’s comprehensive clinical program spans three key sub-specialties—urology, gastroenterology, and radiation oncology—and incorporates a range of ancillary services, including pathology labs, in-office dispensing, and chronic care management. Under the guidance of an accomplished management team, Unio Health Partners delivers a full spectrum of management services to its affiliated practices. With a robust pipeline for future growth, UHP anticipates expanding its platform to include over 200 physicians in the coming years, further solidifying its market presence and impact.
About Triton Pacific Capital Partners
Based in Los Angeles, Triton Pacific Capital Partners is a seasoned private equity firm with a strong track record in healthcare investments. With a portfolio of over 50 private equity investment partnerships and a public, non-traded BDC, Triton Pacific has successfully completed 27 private equity transactions. The firm’s dedicated healthcare investment team brings specialized expertise to sourcing, acquiring, and managing healthcare investments. Unio Health Partners represents the healthcare team’s ninth platform investment, underscoring Triton Pacific’s commitment to the healthcare sector and its confidence in the vision of Unio Health Partners.
